Latest Cambridge News | Page 9

Tezspire recommended for approval in EU by CHMP for treatment of severe asthma
Ultomiris recommended for approval in EU by CHMP for treatment of adults with generalised myasthenia gravis
Leading scientists use Genomics England data set to propose updated global guidelines to improve rare disease diagnosis
Boeing Announces Research Project with University of Cambridge to Further Advance Aviation Impact Accelerator
Touching nerve in equine medicine
Ashurst advises LGC on sale of drug development solutions business
Dr. Joshua Shulman named co-director of Jan and Dan Duncan NRI
Final section of Waikato Expressway now open
Out of Control Gathering – West Leederville
AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline
Strengthening NZ-UK people, science and trade connections
Ten organisations account for half of all animal research in Great Britain in 2021
Körber European Science Prize 2022 for Anthony Hyman
Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial
New chronic kidney disease study indicates that CKD is present in one out of ten adults
Waikato Expressway speed limit to change to 110km/h
Lynparza recommended for approval in EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative
“Unprecedented workshop” highlights new infrastructure delivery methods
Patrick Cramer appointed new President-elect of Max Planck Society as of June 2023
Preferred Option Design for Greater South East Irrigation Scheme announced
Britains earliest humans
Appointment: Brad Jones as Assistant Governor, Financial System Group
Eplontersen met co-primary and secondary endpoints in interim analysis of NEURO-TTRansform Phase III trial for hereditary
NZ police are responding to serious crash, Te Awamutu
What if Monet were shorter?
NSW police charge man with 18 x firearms and prohibited weapons offences
$70,000 fine for building directors’ fraudulent and deceptive conduct
Received & Determined Development Applications 15 June
Prehistoric Swiss Army knife indicates early humans communicated
UNSW places 45th in QS world university rankings
Evusheld significantly prevented Covid disease progression or death in TACKLE Phase III treatment trial
Switch-off and help save up to five billion litres of water this winter
Supporting Our Science Students
NZ police release name over Cambridge tree fall incident
Vaxzevria approved in EU as third dose booster against Covid
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
WHO Director-General announces Global Health Leaders Awards
Waste champions recognised at 2022 WasteSorted Awards
$3.3 Million to Understand Generational Health Challenges that Influence Dementia Prevalence
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against Covid
PT027, novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine
Sea ice can control Antarctic ice sheet stability, new research finds
Canterbury astronomers spot quadruple stars which may spark supernova explosions
Origin of fascination: childhood dream reality for new ARCHE Director
HKUST President Prof. Wei SHYY Honored by French Government
IBD causing bacteria discovered in mice
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial